We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Dermatology

Dermatology

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Approved Monoclonal Antibody Therapies for Hidradenitis Suppurativa: Efficacy, Safety, and Economic Assessments
Clinical UpdatesbiologicsCost-Effectiveness

Approved Monoclonal Antibody Therapies for Hidradenitis Suppurativa: Efficacy, Safety, and Economic Assessments

By MedXY|Aug 11, 2026

This review synthesizes current evidence on adalimumab, secukinumab, and bimekizumab for moderate-to-severe hidradenitis suppurativa, emphasizing clinical efficacy, safety, mechanistic insights, and cost-effectiveness across diverse health

Dynamic Risk Stratification of Melanocytic Lesions with Peripheral Globules: Insights from a Longitudinal Cohort Study
Dermatologyrisk stratificationmelanocytic lesions

Dynamic Risk Stratification of Melanocytic Lesions with Peripheral Globules: Insights from a Longitudinal Cohort Study

By MedXY|Aug 11, 2026

Longitudinal monitoring reveals that persistence and growth dynamics of peripheral globules in melanocytic lesions predict melanoma risk more accurately than static features alone, informing tailored surveillance strategies.

Enfortumab Vedotin-Induced Cutaneous Toxicity: A Marker of Improved Survival in Advanced Urothelial Carcinoma
DermatologysurvivalAntibody-drug conjugate

Enfortumab Vedotin-Induced Cutaneous Toxicity: A Marker of Improved Survival in Advanced Urothelial Carcinoma

By MedXY|Aug 7, 2026

Enfortumab vedotin (EV) therapy in advanced urothelial carcinoma is frequently associated with cutaneous adverse events (cAEs). These EV-induced skin toxicities correlate independently with improved progression-free and overall survival, ev

Efficacy of Antifungal Therapies in Tinea Capitis: Insights from a Multicenter Study in China
Dermatologyitraconazoleterbinafine

Efficacy of Antifungal Therapies in Tinea Capitis: Insights from a Multicenter Study in China

By MedXY|Aug 7, 2026

A multicenter prospective real-world study in China evaluated treatment outcomes of tinea capitis, highlighting itraconazole’s superior efficacy over terbinafine for certain fungal strains like Microsporum canis, informing optimized a

CD19 CAR T-cell Therapy Without Lymphodepletion Shows Promise in Pemphigus Vulgaris: Insights from the RESET-PV Trial
Allergy & ImmunologyAutoimmune DiseasesCD19 CAR T-cell therapy

CD19 CAR T-cell Therapy Without Lymphodepletion Shows Promise in Pemphigus Vulgaris: Insights from the RESET-PV Trial

By MedXY|Aug 2, 2026

Early results from the RESET-PV trial indicate that CD19 CAR T-cell therapy without lymphodepleting preconditioning is feasible and safe for pemphigus vulgaris, offering significant clinical improvement and durable B-cell depletion.

Cost-Effectiveness of Oral Nicotinamide for Keratinocyte Carcinoma Prevention: A Clinical and Economic Review
Clinical UpdatesCost-Effectivenesskeratinocyte carcinoma

Cost-Effectiveness of Oral Nicotinamide for Keratinocyte Carcinoma Prevention: A Clinical and Economic Review

By MedXY|Jul 30, 2026

Oral nicotinamide reduces keratinocyte carcinoma incidence in high-risk individuals, providing significant cost savings and quality-adjusted life-year gains, supporting its role as a cost-effective preventive strategy.

Enhancing Diagnostic Accuracy in Head and Neck Pigmented Macules: The Critical Role of Reflectance Confocal Microscopy
Dermatologyhead and neck pigmented lesionsreflectance confocal microscopy

Enhancing Diagnostic Accuracy in Head and Neck Pigmented Macules: The Critical Role of Reflectance Confocal Microscopy

By MedXY|Aug 4, 2026

Reflectance confocal microscopy (RCM) combined with dermoscopy significantly improves detection and management of equivocal pigmented macules on the head and neck, reducing missed malignancies and overtreatment in a study of 2006 lesions.

Digital Standardized Skin Care Regimen Enhances Outcomes in Patients with Acne-Rosacea Comorbidity: Insights from a Real-World Longitudinal Cohort
Dermatologyacnedigital health

Digital Standardized Skin Care Regimen Enhances Outcomes in Patients with Acne-Rosacea Comorbidity: Insights from a Real-World Longitudinal Cohort

By MedXY|Jul 21, 2026

A digital standardized skin care regimen improves clearance rates, reduces relapse, and enhances quality of life in acne-rosacea comorbidity, mediated partially by epidermal barrier restoration.

Circulating Tumor DNA Outperforms Merkel Cell Polyomavirus Antibodies for Monitoring Recurrence in Merkel Cell Carcinoma
Dermatologycancer surveillancectDNA

Circulating Tumor DNA Outperforms Merkel Cell Polyomavirus Antibodies for Monitoring Recurrence in Merkel Cell Carcinoma

By MedXY|Jul 14, 2026

A multicenter cohort study demonstrates that circulating tumor DNA (ctDNA) is more accurate than Merkel cell polyomavirus (MCPyV) antibody testing in detecting recurrence of Merkel cell carcinoma, improving patient surveillance and risk str

Exploring Institutional and Insurance-Linked Disparities in Melanoma Outcomes: Insights from a VA and Tertiary Care Cohort Study
Dermatologyinsurance disparitiesmelanoma

Exploring Institutional and Insurance-Linked Disparities in Melanoma Outcomes: Insights from a VA and Tertiary Care Cohort Study

By MedXY|Jul 14, 2026

This cohort study reveals differential melanoma survival outcomes linked to institutional settings and insurance types, highlighting the need for standardized care in advanced melanoma stages.

Dispelling Myths: Navigating Patient Misconceptions About Hyaluronic Acid Fillers for Optimal Aesthetic Outcomes
Dermatologyaesthetic medicineclinical practice

Dispelling Myths: Navigating Patient Misconceptions About Hyaluronic Acid Fillers for Optimal Aesthetic Outcomes

By MedXY|Jul 14, 2026

This article addresses common patient misconceptions about hyaluronic acid fillers, elucidating safety, efficacy, and best practice strategies to ensure natural results and improved patient trust.

Optimizing Long-Term Management in Moderate-to-Severe Atopic Dermatitis: Real-World Evidence on 24-Week Abrocitinib Tapering Strategies
Allergy & ImmunologyAbrocitinibatopic dermatitis

Optimizing Long-Term Management in Moderate-to-Severe Atopic Dermatitis: Real-World Evidence on 24-Week Abrocitinib Tapering Strategies

By MedXY|Jul 12, 2026

This article reviews a retrospective study evaluating the feasibility and outcomes of a 24-week abrocitinib tapering regimen in moderate-to-severe atopic dermatitis, comparing dose reduction versus interval extension approaches and their im

When to Image: Expert Consensus on Staging and Surveillance Imaging for Cutaneous Squamous Cell Carcinoma
Dermatologycutaneous squamous-cell carcinomaimaging

When to Image: Expert Consensus on Staging and Surveillance Imaging for Cutaneous Squamous Cell Carcinoma

By MedXY|Jul 12, 2026

A multidisciplinary Delphi panel offers practical, consensus-based recommendations to standardize when and how to use staging and surveillance imaging for localized cutaneous squamous cell carcinoma (CSCC).

Feasibility and Comparative Outcomes of 24-Week Abrocitinib Tapering in Moderate-to-Severe Atopic Dermatitis
Allergy & ImmunologyAbrocitinibatopic dermatitis

Feasibility and Comparative Outcomes of 24-Week Abrocitinib Tapering in Moderate-to-Severe Atopic Dermatitis

By MedXY|Jul 12, 2026

This study evaluates the successful 24-week tapering of abrocitinib in moderate-to-severe atopic dermatitis patients, comparing dose reduction versus interval extension tapering regimens and demonstrating high feasibility with substantial d

High-Frequency Ultrasound in Managing Palpable Indurations After Cosmetic Filler Injections: Diagnostic Precision and Guided Therapeutics
Dermatologycosmetic fillershigh-frequency ultrasound

High-Frequency Ultrasound in Managing Palpable Indurations After Cosmetic Filler Injections: Diagnostic Precision and Guided Therapeutics

By MedXY|Jul 12, 2026

This retrospective analysis demonstrates high-frequency ultrasound’s efficacy in diagnosing palpable indurations post-cosmetic filler injection, enabling tailored treatment strategies that improve clinical outcomes and minimize intervention

Large-Scale Meta-Analysis Finds Higher Influenza and Shingles Risk with JAK-STAT Inhibitors
Dermatologyatopic dermatitisInfection Risk

Large-Scale Meta-Analysis Finds Higher Influenza and Shingles Risk with JAK-STAT Inhibitors

By MedXY|May 27, 2026

A large meta-analysis found JAK-STAT inhibitors slightly increased influenza, bronchitis, and herpes zoster risk, especially in atopic dermatitis, while serious and opportunistic infections were not significantly increased.

Hospital-Acquired DRESS and Clinical Severity Strongly Predict ICU Admission in a 39-Centre Paris Cohort
Critical CareDRESS syndromedrug hypersensitivity

Hospital-Acquired DRESS and Clinical Severity Strongly Predict ICU Admission in a 39-Centre Paris Cohort

By MedXY|May 27, 2026

In this multicentre cohort of 207 hospitalized adults with DRESS, 17% required ICU care. Hospital-acquired DRESS and greater clinical severity independently predicted ICU admission, while ICU mortality reached 20%.

A New CTCL-Specific Quality-of-Life Tool Shows Strong Early Validity Signals in Cutaneous T-Cell Lymphoma
DermatologyCTCL-PRO-20Cutaneous T-Cell Lymphoma

A New CTCL-Specific Quality-of-Life Tool Shows Strong Early Validity Signals in Cutaneous T-Cell Lymphoma

By MedXY|May 11, 2026

A single-center validation study suggests the CTCL-PRO-20 may provide a reliable, disease-specific measure of quality of life in patients with cutaneous T-cell lymphoma.

Navigating Scrotal Health: A Comprehensive Guide to Lymphedema and Excessive Sweating
Dermatologydermatologymen's health

Navigating Scrotal Health: A Comprehensive Guide to Lymphedema and Excessive Sweating

By MedXY|Mar 8, 2026

This article provides an in-depth exploration of scrotal lymphedema and hyperhidrosis, detailing their physiological causes, clinical symptoms, and the latest management strategies for both patients and healthcare providers.

Sopoongsan Attenuates Chronic Pruritus via STAT1 Inhibition: Evidence from a Randomized Pilot Trial and Translational Models
Allergy & Immunologyatopic dermatitisChronic Pruritus

Sopoongsan Attenuates Chronic Pruritus via STAT1 Inhibition: Evidence from a Randomized Pilot Trial and Translational Models

By MedXY|Mar 6, 2026

A pilot randomized controlled trial and translational study demonstrate that Sopoongsan (SPS) effectively reduces chronic upper body pruritus in atopic and seborrheic dermatitis by inhibiting STAT1-mediated inflammatory pathways, offering a

Prev
2 / 7
1234…7
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities

Browse by specialty

Open language-specific specialty feeds and department pages.

news6629 articlesCardiology1375 articlesClinical Updates1288 articlesOncology1139 articlesDiabetes & Endocrinology842 articlesNeurology820 articlesPublic Health595 articlesGastroenterology572 articles
Hematology-Oncology
487 articles
Pediatrics484 articles
Internal Medicine444 articles